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1. Introduction and aims 
The majority of estrogen-dependent diseases might be treated by antihormonal drugs. 
Estrone-based drugs acting through inhibition of enzymes involved in estrogen biosynthesis 
usually have estrogenic activity, which is an undesirable side-effect. The development of drugs 
acting selectively is one of the major challenges in medicinal chemistry. Directed substitutions of 
ring A of estrone lead to compounds which may have substantial enzyme inhibitory effect 
against key enzymes in estrogen biosynthesis. Our aim was to synthesize selectively acting 
enzyme inhibitors based on hormonally inactive 13α-estrane core modified in ring A. We began 
our synthetic organic work with aromatic electrophilic substitutions furnishing halogenated 13α-
estrone derivatives. The newly synthesized iodo and bromo derivatives proved to be suitable 
starting compounds for novel Pd-catalyzed C–C or C–N cross-coupling reactions in the 13-epi-
estrone series. We have developed efficient microwave-assisted Sonogashira and Buchwald–
Hartwig coupling procedures, which tolerated different functional groups present on ring A and 
allowed the formation of the desired coupled products even at sterically hindered positions. Our 
additional aim was to synthesize fluorescent-labelled estrone derivatives based on BODIPY 
dyes. The labelling was planned without the involvement of the main oxygen functionalities of 
estrone. Thus estrone-BODIPY conjugates labelled at C-2 or C-15 were synthesized, which may 
serve as good candidates for the development of imaging probes for biochemical assays. 
 
2. Applied methods 
Most reactions were carried out on a millimolar scale, and were monitored by thin-layer 
chromatography. CuAAC reactions were carried out by conventional heating and palladium-
catalyzed cross couplings were performed in a CEM Discover SP microwave reactor. The 
purification of the reaction mixtures and the separation of the products were accomplished by 
flash chromatography. The structures of the new compounds were confirmed mainly by one- and 
two-dimensional NMR spectroscopic techniques. 
 
3. Novel scientific results 
3.1. Introduction of halogens onto the aromatic ring of 13α-estrone with different protecting 
groups at position 3 (OH, OMe, OBn) was performed (Scheme 1). Chlorination, bromination or 
iodination was carried out with N-halosuccinimides (NXS) as electrophile triggers in different 
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solvents. In the 3-OH series both 2- and 4-substituted regioisomers were formed and 2,4-bis-
substitutions also occurred. The reactions were completed in short reaction times and the 
mixtures of the desired products could efficiently be separated by flash chromatography.  
3.2. The influence of the solvent applied and the quantity of reactant on product yields of the 
reactions discussed in 3.1. was investigated. It can be stated that conversions can be influenced 
by changing the solvent of the reaction. The most extreme example was the 2-bromo derivative 
of 13α-estrone, which formed only in dimethyl sulfoxide. The use of excess NXS in the reactions 
of 13α-estrone facilitates double substitution. 
3.3. The impact of 3-methyl or 3-benzyl protecting groups on halogenations was investigated 
(Scheme 1). Substantial differences were found in product ratios. Monosubstitutions occurred in 
the 3-ether series, while halogenations of the phenolic starting compound led to both mono- and 
disubstituted derivatives. Iodination of the 3-benzyl ether could not be achieved via this method. 
Most reactions were carried out at room temperature. Chlorination of 3-ethers, however, required 
harsh conditions, namely, elevated temperature and the use of trifluoroacetic acid. 
3.4. Halogenations of 17-deoxy-13α-estrone were carried out using N-halosuccinimides in 
different solvents furnishing 2-, 4- as well as 2,4-bis-substituted regioisomers (Scheme 1). We 
found that the presence or absence of the 17-keto function has great influence on the product 
ratio. A comparison of the results obtained in the halogenation of 17-oxo and 17-deoxy starting 
compounds allowed the conclusion that, depending on the nature of the C-17 substituent, 
different conditions are needed for the convenient synthesis of the desired mono- and 
disubstituted compounds. Chlorination of 17-deoxy-13α-estrone required the combination of 
reagent excess and microwave irradiation. 
 
Scheme 1 
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3.5. A convenient synthetic microwave procedure was developed for the Sonogashira coupling 
of 2-iodo-3-O-methyl-13α-estrone (Scheme 2). Couplings at C-2 could efficiently be achieved 
using 0.1 equiv of Pd(PPh3)4 and CuI in dimethylformamide (DMF) as solvent in the presence of 
Et3N as a base, at 50 °C for 20 min in a microwave reactor. After establishing the most favorable 
reaction conditions for phenylacetylene as alkyne partner, Sonogashira reactions were carried out 
with several para-substituted phenylacetylenes (C6H5R
2
). All couplings resulted in the desired 
products in high yields, irrespective of the nature of the substituent at C-4’. The method was 
successfully adapted to compounds with C-3 phenolic OH by changing the solvent to 
acetonitrile. 
3.6. The method discussed in 3.5. was successfully adapted to coupling of 4-iodo-3-O-methyl-
13α-estrone with phenylacetylene by minor changes in reaction conditions (Scheme 2). We 
found that elevation of the reaction temperature to 80 °C and the change of catalyst to 
Pd(PPh3)2Cl2 facilitate substitution at C-4. The reaction of 4-iodo-13α-estrone bearing phenolic 
OH required the changing of solvent to tetrahydrofuran. We isolated the desired 4-phenethynyl-
3-hydroxy derivative in excellent yield. The method was successfully adapted to the synthesis of 
4-(4’-subst.)phenethynyl-13α-estrone derivatives bearing various 4’-substitutents.  
 
Scheme 2 
3.7. We performed the partial saturation of 3-O-methyl-4’-methoxy-13α-estrone derivatives by 
semihydrogenation using DMF/KOH as the hydrogen source and Pd(PPh3)2Cl2 as the catalyst 
(Scheme 3). Full conversion of the starting compounds was achieved in 35 minutes by 
microwave irradiation. Both cis-alkenes and trans-alkenes were formed in chemo- and 
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stereoselective manner under the applied conditions from 2- and 4-phenethynyl derivatives, 
respectively. The cis or trans orientation of the resulting geometric isomers was deduced from 
vicinal coupling constants. 
 
Scheme 3 
3.8. Semihydrogenation of triple bonds of 3-hydroxy-4’-methoxy derivatives did not result in the 
desired 2- or 4- phenethenyl compounds by the method discussed in 3.7 (Scheme 4). Under the 
conditions used for partial saturation, the ethynyl derivatives bearing a phenolic OH group 
furnished benzo[b]furans.  
 
Scheme 4 
3.9. Full hydrogenation of the 3-hydroxy- or 3-O-methyl-4’-methoxy derivatives with palladium-
on-charcoal furnished the desired 2- or 4-phenethyl-substituted compounds (Scheme 5). The 
products were formed under 20 bar H2 in ethyl acetate in excellent yields.  
 
Scheme 5 
5 
 
3.10. We have developed an efficient protocol for the Buchwald–Hartwig amination of 2-bromo-
3-O-methyl-13α-estrone with aniline (Scheme 6). An optimization process was performed by the 
systematic change of catalyst, base and ancillary ligand. We found that the outcome of the 
couplings greatly depends on the applied conditions. A comparison of conventional heating and 
microwave-assisted heat transfer was investigated observing significantly shortened reactions 
under microwave irradiation. Optimal reaction conditions were identified. The highest yields 
were achieved by using Pd(OAc)2 as catalyst, KO
t
Bu as base and XPhos as ancillary ligand at 
100 °C in a microwave reactor. 
3.11. With the best reaction conditions in hand (discussed in 3.10.), the couplings at C-2 of 2-
bromo-3-O-methyl-13α-estrone were extended to monosubstituted anilines bearing electronically 
different substituents at otho, meta or para positions (Scheme 6). All couplings proceeded with 
high yields. The best yields were achieved with nitroanilines, irrespective of the position of the 
nitro group. Reactions of methylanilines led to slightly lower yields, indicating that the presence 
of the electron-donating methyl group is less advantageous.  
 
Scheme 6 
3.12. The coupling at C-4 of 4-bromo-3-O-methyl-13α-estrone with aniline under the conditions 
mentioned above yielded the 4-phenylamino derivative in high yield (Scheme 7). Irrespective of 
the more bulky nature of the benzyl ether group, both 3-O-benzyl-2-bromo- and -4-bromo-13α-
estrone were successfully aminated without the need for changing the reaction conditions 
established for couplings at C-2. 
 
Scheme 7 
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3.13. The efficient C(sp
2
)–N coupling method elaborated in 3.10. proved to be suitable for the 
reaction of 2- or 4-bromo regioisomers in both the 3-O-methyl and 3-O-benzyl series with 
benzophenone imine as an amine precursor (Scheme 8). The resulting 2- or 4-(N-
diphenylmethylideneamino)-13α-estrones could efficiently be transformed into the appropriate 
amino counterparts. Deprotection was achieved by Brønsted acid in the case of 3-methyl ethers 
and via hydrogenolysis from 3-benzyl ethers using palladium-on-charcoal catalyst. Concerning 
3-benzyl ethers, deprotection of the 3-OH and liberation of the 2-NH2 functions occurred 
simultaneously. Thus, the combination of the elaborated convenient C(sp
2
)–N coupling 
procedure with deprotection led to the desired 2-amino-13α-estrone in only two steps with high 
overall yield. 
 
Scheme 8 
3.14. BODIPY
1
-alkyne a known compound was synthesized using the aldehyde–pyrrole 
condensation strategy by newly established procedure based on the modification and 
combination of literature methods (Scheme 9). After the propargylation of para-
hydroxybenzaldehyde, the dipyrrolylmethane core was built via trifluoroacetic acid (TFA)-
catalyzed condensation of the formed aldehyde and pyrrole. Subsequent oxidation of 
dipyrrolylmethane with DDQ (2,3-dichloro-5,6-dicyano-para-benzoquinone) and complexation 
with BF3OEt2 furnished the desired BODIPY
1
-alkyne in high yield. 
 
Scheme 9 
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3.15. A new BODIPY derivative bearing the azide function was synthesized using the acyl 
chloride–pyrrole condensation strategy (Scheme 10). Trisubstituted pyrrole was selected for the 
condensation in order to avoid the formation of side-products. ω-Bromovaleric acid was used as 
the azide precursor in order to build in a four-carbon-long spacer chain to the conjugate. The 
required acyl chloride was formed in situ with oxalyl chloride. Condensation of the acyl chloride 
and pyrrole allowed the selective formation of dipyrrolylmethene. Subsequent complexation with 
BF3OEt2 without isolation of the intermediate led to the bromo-BODIPY
2
 product in high yield. 
The new BODIPY
2
-azide was formed in a bromine-to-azide exchange reaction. 
 
Scheme 10 
3.16. The Δ15,16-estrone was transformed into the appropriate alkyne or azide derivative by 
Michael addition (Scheme 11). The terminal alkyne function was introduced onto C-15 via O-
propargylation with propargyl alcohol in dichloromethane, using a catalytic amount of NaOH as 
the base. The 15-azide derivative was synthesized via the addition of HN3 formed in situ from 
NaN3 and acetic acid. The nucleophilic attack onto C-15 occurred in a stereoselective fashion in 
both cases leading to the formation of a single stereoisomer (15β). The 15β orientation of the O-
propargyl substituent was deduced from the NOESY NMR spectrum showing a cross-peak 
between the signals of 15α-H and 16α-H. 
 
Scheme 11 
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3.17. With estrone and BODIPY alkyne and azide in hand, we carried out Cu(I)-catalyzed 
azide–alkyne conjugation (CuAAC) reactions in order to synthesize the desired fluorescent 
estrone conjugates (Scheme 12). CuAAC conditions were applied according to the protocol 
developed previously by our research group. Conjugations were achieved using CuI as the 
catalyst, PPh3 as the ligand, and DIPEA as the base under conventional heating in toluene 
solvent. Reactions led to the desired fluorescent estrone-BODIPY conjugates in excellent yields. 
 
Scheme 12 
3.18. Fluorescent labelling of estrone through ring A was achieved (Scheme 13). The terminal 
alkyne function was introduced directly onto the C-2 position in two steps. Sonogashira 
coupling of 2-iodoestrone with trimethylsilylacetylene (TMSA) was performed via our 
microwave-assisted procedure established earlier (see 3.5.). Deprotection of 2-
trimethylsilylethynyl-estrone was carried out with tetrabutylammonium fluoride (TBAF) in situ 
during the CuAAC reaction. The fluorescent estrone-BODIPY conjugate was isolated in high 
yield via the procedure discussed in 3.17. 
 
Scheme 13 
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